Impact of psychosocial comorbidities on clinical outcomes after liver transplantation: Stratification of a high-risk population.

Liver transplantation Non-compliance Psychosocial decompensation Recidivism Transplant psychiatry

Journal

World journal of hepatology
ISSN: 1948-5182
Titre abrégé: World J Hepatol
Pays: United States
ID NLM: 101532469

Informations de publication

Date de publication:
27 Aug 2019
Historique:
received: 20 03 2019
revised: 23 05 2019
accepted: 16 07 2019
entrez: 19 9 2019
pubmed: 19 9 2019
medline: 19 9 2019
Statut: ppublish

Résumé

Liver transplantation is the accepted standard of care for end-stage liver disease due to a variety of etiologies including decompensated cirrhosis, fulminant hepatic failure, and primary hepatic malignancy. There are currently over 13000 candidates on the liver transplant waiting list emphasizing the importance of rigorous patient selection. There are few studies regarding the impact of additional psychosocial barriers to liver transplant including financial hardship, lack of caregiver support, polysubstance abuse, and issues with medical non-compliance. We hypothesized that patients with certain psychosocial comorbidities experienced worse outcomes after liver transplantation. To assess the impact of certain pre-transplant psychosocial comorbidities on outcomes after liver transplantation. A retrospective analysis was performed on all adult patients from 2012-2016. Psychosocial comorbidities including documented medical non-compliance, polysubstance abuse, financial issues, and lack of caregiver support were collected. The primary outcome assessed post-transplantation was survival. Secondary outcomes measured included graft failure, episodes of acute rejection, psychiatric decompensation, number of readmissions, presence of infection, recidivism for alcohol and other substances, and documented caregiver support failure. For the primary outcome, there were no differences in survival. Patients with a history of psychiatric disease had a higher incidence of psychiatric decompensation after liver transplantation (19% Patients with certain psychosocial comorbidities had worse outcomes following liver transplantation. Further prospective and multi-center studies are warranted to properly determine guidelines for liver transplantation regarding this high-risk population.

Sections du résumé

BACKGROUND BACKGROUND
Liver transplantation is the accepted standard of care for end-stage liver disease due to a variety of etiologies including decompensated cirrhosis, fulminant hepatic failure, and primary hepatic malignancy. There are currently over 13000 candidates on the liver transplant waiting list emphasizing the importance of rigorous patient selection. There are few studies regarding the impact of additional psychosocial barriers to liver transplant including financial hardship, lack of caregiver support, polysubstance abuse, and issues with medical non-compliance. We hypothesized that patients with certain psychosocial comorbidities experienced worse outcomes after liver transplantation.
AIM OBJECTIVE
To assess the impact of certain pre-transplant psychosocial comorbidities on outcomes after liver transplantation.
METHODS METHODS
A retrospective analysis was performed on all adult patients from 2012-2016. Psychosocial comorbidities including documented medical non-compliance, polysubstance abuse, financial issues, and lack of caregiver support were collected. The primary outcome assessed post-transplantation was survival. Secondary outcomes measured included graft failure, episodes of acute rejection, psychiatric decompensation, number of readmissions, presence of infection, recidivism for alcohol and other substances, and documented caregiver support failure.
RESULTS RESULTS
For the primary outcome, there were no differences in survival. Patients with a history of psychiatric disease had a higher incidence of psychiatric decompensation after liver transplantation (19%
CONCLUSION CONCLUSIONS
Patients with certain psychosocial comorbidities had worse outcomes following liver transplantation. Further prospective and multi-center studies are warranted to properly determine guidelines for liver transplantation regarding this high-risk population.

Identifiants

pubmed: 31528246
doi: 10.4254/wjh.v11.i8.638
pmc: PMC6717712
doi:

Types de publication

Journal Article

Langues

eng

Pagination

638-645

Déclaration de conflit d'intérêts

Conflict-of-interest statement: No potential conflicts of interest relevant to this article were reported.

Références

Hepatology. 2002 Jan;35(1):105-9
pubmed: 11786965
Gastroenterology. 2003 Jan;124(1):91-6
pubmed: 12512033
Liver Transpl. 2003 Jul;9(7):712-20
pubmed: 12827558
J Psychiatr Pract. 2001 Nov;7(6):404-14
pubmed: 15990553
Transplant Proc. 2008 Apr;40(3):782-4
pubmed: 18455016
Am J Gastroenterol. 2009 Jul;104(7):1700-6
pubmed: 19471253
Liver Transpl. 2011 Mar;17(3):251-60
pubmed: 21384507
Liver Transpl. 2011 Jul;17(7):760-70
pubmed: 21384527
Liver Transpl. 2011 Aug;17(8):881-90
pubmed: 21563295
Int J Hepatol. 2011;2011:121862
pubmed: 22007310
N Engl J Med. 2011 Nov 10;365(19):1790-800
pubmed: 22070476
Curr Opin Organ Transplant. 2012 Apr;17(2):188-92
pubmed: 22277955
Psychosomatics. 2012 Mar-Apr;53(2):123-32
pubmed: 22424160
Transplantation. 1990 Feb;49(2):374-7
pubmed: 2305467
Curr Opin Organ Transplant. 2014 Jun;19(3):217-22
pubmed: 24807211
Psychol Health Med. 2016 Jun;21(4):525-529
pubmed: 26549304
Am J Transplant. 2016 Mar;16(3):841-9
pubmed: 26710309
PLoS One. 2016 Nov 7;11(11):e0165517
pubmed: 27820828
BMC Gastroenterol. 2016 Nov 15;16(1):137
pubmed: 27846801

Auteurs

Neil Bhogal (N)

Department of Internal Medicine, Division of Gastroenterology and Hepatology, University of Nebraska Medical Center, Omaha, NE 68198, United States, neil.bhogal@unmc.edu.

Amaninder Dhaliwal (A)

Department of Internal Medicine, Division of Gastroenterology and Hepatology, University of Nebraska Medical Center, Omaha, NE 68198, United States.

Elizabeth Lyden (E)

Department of Biostatistics, Division of Public Health, University of Nebraska Medical Center, Omaha, NE 68198, United States.

Fedja Rochling (F)

Department of Internal Medicine, Division of Gastroenterology and Hepatology, University of Nebraska Medical Center, Omaha, NE 68198, United States.

Marco Olivera-Martinez (M)

Department of Internal Medicine, Division of Gastroenterology and Hepatology, University of Nebraska Medical Center, Omaha, NE 68198, United States.

Classifications MeSH